After five weeks, the combination treatment in the six mice decreased tumor size by up to 66 percent, compared with six mice treated with only paclitaxel.
Combining Paclitaxel with Nutlin - 3 not only potentiated the tumor response to Paclitaxel, but also prevented Numb - deficient tumors from re-growing after treatment discontinuation.